Martin Copeland, OD
Optometrist · Freeport, NYNPI 1215901038
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,170 of the $3,589 with a category attached, or 60.5%. Coopervision Inc. accounts for 70.7% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $3,143, more than ten times the $80 reported in 2019.
Across 34 payments — averaging $105.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coopervision Inc.$3K
- Alcon$715
- Johnson & Johnson Vision Care, Inc.$206
- Johnson & Johnson Surgical Vision, Inc.$37
- Bausch & Lomb Americas Inc.$36
- Quidel Corporation$23
- plus $34 from 2 others
What the payments were for
- Speaking & faculty fees$50014%
- Travel & lodging$2,17060%
- Food & beverage$89925%
- Gifts$191%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coopervision Inc. | 7 | $2,538 |
| Alcon | 6 | $715 |
| Johnson & Johnson Vision Care, Inc. | 14 | $206 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $37 |
| Bausch & Lomb Americas Inc. | 2 | $36 |
| Quidel Corporation | 1 | $23 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Tarsus Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CVI Contact Lens$2,170
- DAILIES TOTAL1$500
- Air Optix Color$500
- Precision 1$500
- Precision7$124
How this compares
$3,589 in reported general payments places this provider in the 85th percentile of 2,743 optometrist providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 18 | $11,784 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 11 | $109 |
| Latanoprost | 19 | $102 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Freeport
- Roy KlineLake Katrine$822K
- Susan ResnickNew York$463K
- Murray FingeretHewlett$374K
- Albert MorierSlingerlands$347K
- Denise WhittamNew York$343K
- Justin BazanBrooklyn$303K
- Jennifer TsaiNew York$275K
- Alexander KabiriQueens Village$268K
- Sophia VisanjiNew York$233K
- Jason ComptonNew York$181K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.